Right Turn: Every damn swan – a note on the scientific hypothesis

Author: Guest, 12/02/16

Malgosia Pakulska is a research associate in the Shoichet lab at the University of Toronto and a science writer for Research2Reality, a blog designed to engage the public in Canadian research. Malgosia wants to educate, entertain, and show people what science is really like, one story at a time. When she is not in the lab,…Read more

Insights from CGTW16 – Part 3: Clinical trials, health economics and regulatory affairs

Author: Guest, 12/01/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Right Turn: A proliferating list of popular podcasts

Author: Stacey Johnson, 11/25/16

Podcasts have been around since the 1980s and with 250,000 unique podcasts in more than 100 languages, according to Apple, you can probably find one that covers any topic you care to search for. Back in 2014, Lisa Willemse encouraged Signals’ readers to tune in to The Stem Cell Podcast and I mentioned them last…Read more

Insights from CGTW16 – Part 2: scale-up challenges and closed systems

Author: Guest, 11/23/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Right Turn: These three videos show why we should be impressed by our young stem cell researchers

Author: Lisa Willemse, 11/18/16

Stroke, lung damage and mathematical modeling. You may not think these three topics have much in common and for the most part you’d be right. But they have more than one common link. First, each is either a disease focus or methodology within stem cell research. Secondly, each subject –biomaterials to aid stem cell engraftment…Read more

Insights from CGTW16 – Part 1: Cell Manufacturing Best Practices

Author: Guest, 11/17/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Can we defy aging?

Author: Jovana Drinjakovic, 11/14/16

Last month, a paper published in Nature grabbed headlines by claiming that human lifespan is capped at 115 years. As disappointing as the news may be to anyone wanting to live forever, I’m okay with this shelf life, so long as I can be an energetic, pain-free supercentenarian. Still, despite tangible progress in medicine that…Read more

Right Turn: What do the results of the U.S. election mean for science?

Author: Stacey Johnson, 11/09/16

This isn’t the blog that I planned to write this week, but I’m so preoccupied with the outcome of the U.S. election, I’m finding it hard to focus on anything else right now. So, let’s look at the implications of a Trump presidency on science. An article in Nature quotes Michael Lubell, director of public…Read more

Making connections – advancing regenerative medicine through partnerships

Author: Nicole Forgione, 11/08/16

A key driver for advancements in regenerative medicine is partnerships. In recognition of this, every year CCRM hosts a networking reception that brings together our partners for an evening of discussion and knowledge sharing. This year’s industry networking reception was focused on the theme of increasing partnerships between industry and academia. I had the privilege…Read more

Right Turn: The story of scurvy is a poignant cautionary tale for modern medical science

Author: Guest, 11/04/16

Elizabeth (Liz) Csaszar is a development manager for the BridGE team at CCRM. Her areas of interest are cell manufacturing, clinical translation of cell based therapies, and blood cell technologies. Liz obtained her PhD at the University of Toronto, focusing on the strategies to expand and self-renew hematopoietic stem cells in vitro. Liz is interested in…Read more